Access to colposcopy services for high-risk Canadian women: Can we do better?

Canadian Journal of Public Health

Volumn 95, Issue 5, 2004, Pages 346-351

  Ogilvie, Gina S ^a   Shaw, Elizabeth A ^b   Lusk, Sandra P ^b   Zazulak, Joyce ^b   Kaczorowski, Janusz A ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; COLPOSCOPY; COMMUNITY CARE; CONSULTATION; EVALUATION; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH PROGRAM; HEALTH SERVICE; HIGH RISK POPULATION; HUMAN; IMMIGRANT; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PATIENT REFERRAL; RETROSPECTIVE STUDY; SOCIOECONOMICS; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER;

EID: 4944221577     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03405143     Document Type: Article

References (35)

1. Health Canada. Cervical Cancer in Canada. Ottawa: Laboratory Centre for Disease Control, Health Protection Branch, Health Canada. 1998.
2. SOGC Policy and Practice Guidelines Committee. Management of Abnormal Papanicoloau Smear. Journal of SOGC 2004;20:57-64.
3. Kinlen LJ, Spriggs AI. Women with positive cervical smears but without surgical intervention. A follow-up study. Lancet 1978;2:463-65.
4. Carmichael JA, Jeffrey JF, Steele HD, Ohlke ID. The cytologic history of 245 patients developing invasive cervical carcinoma. Am J Obstet Gynecol 1984;148:685-90.
5. Band PR, Gallagher RP, Threlfall WJ, Hislop TG, Deschamps M, Smith J. Rate of death from cervical cancer among native Indian women in British Columbia. CMAJ 1992;147:1802-4.
6. Hislop TG, Band PR, Deschamps M, Clarke HF, Smith JM, Ng VT. Cervical cancer screening in Canadian Native women. Adequacy of the Papanicolaou smear. Acta Cytologica 1994;38:29-32.
7. Hislop TG, Mumick GC, Yelland L. Invasive cervical cancer among South Asian women in British Columbia. BC Medical J 1995;37:697-99.
8. Miller AB, Anderson G, Brisson J, Laidlaw J, Le Pitre N, Malcolmson P, et al. Report of a National Workshop on Screening for Cancer of the Cervix. CMAJ 1991;145:1301-25.
9. Health Canada. Programmatic Guidelines for Screening for Cancer of the Cervix in Canada. Society of Gynecologic Oncologists of Canada, Health Canada, 1998.
10. Sanders G, Craddock C, Wagstaff I. Factors influencing default at a hospital colposcopy clinic. Quality in Health Care 1992;1:236-40.
11. Laedtke TW, Dignan M. Compliance with therapy for cervical dysplasia among women of low socio-economic status. [see comment]. Southern Medical J 1992;85:5-8.
12. Lerman C, Hanjani P, Caputo C, Miller S, Delmoor E, Nolte S, Engstrom P. Telephone counseling improves adherence to colposcopy among lower-income minority women. J Clin Oncol 1992;10:330-33.
13. Lester H, Wilson S. Is default from colposcopy a problem, and if so what can we do? A systematic review of the literature. Br J Gen Pract 1999;49:223-29.
14. Usha Kiran TS, Jayawickrama NS. Who are the women who default from colposcopy clinics? J Obstet Gynaecol 2002;22:537-39.
15. Miller SM, Siejak KK, Schroeder CM, Lerman C, Hernandez E, Helm CW. Enhancing adherence following abnormal Pap smears among low-income minority women: A preventive telephone counseling strategy. J Natl Cancer Inst 1997;89:703-8.
16. Marcus AC, Kaplan CP, Crane LA, Berek JS, Bernstein G, Gunning JE, McClatchey MW. Reducing loss-to-follow-up among women with abnormal Pap smears. Results from a randomized trial testing an intensive follow-up protocol and economic incentives. Medical Care 1998;36:397-410.
17. Yabroff KR, Kerner JF, Mandelblatt JS. Effectiveness of interventions to improve follow-up after abnormal cervical cancer screening. Prev Med 2000;31:429-39.
18. Martin BD, Smith WL, Orr P, Guijon F. Follow-up of a decentralized colposcopy program for the investigation and management of cervical intraepithelial neoplasia in the central Canadian Arctic. Int J Circumpolar Health 1998;57(Suppl 1):406-9.
19. Healey SM, Aronson KJ, Mao Y, Nicholas F, Mery LS, Ferenczy A, Franco E. Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada. Sex Transm Dis 2001;28:694-700.
20. Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev 2000;9:945-51.
21. BC Cancer Agency. Cervical Cancer Screening Program Annual Report. Vancouver, BC: BC Cancer Agency, 2000.
22. Rice J, Feightner J. North Hamilton Community Health Survey. Hamilton, ON: North Hamilton CHC, 1997.
23. Statistics Canada. Census, 1996: Profile of Census Divisions and Subdivisions in Ontario. Ottawa, ON: Minister of Industry, Science and Technology, 1996.
24. Hislop TG, Clarke HF, Deschamps M, et al. Cervical cytology screening. How can we improve rates among First Nations women in urban British Columbia? Can Fam Phys 1996;42:1701-8.
25. Goel V. Factors associated with cervical cancer screening: Results from the Ontario Health Survey. Can J Public Health 1994;85:125-27.
26. Maxwell CJ, Bancej CM, Snider J, Vik SA. Factors important in promoting cervical cancer screening among Canadian women: Findings from the 1996-97 National Population Health Survey (NPHS). Can J Public Health 2001;92:127-33.
27. Yassin AS, Howell RJ, Nysenbaum AM. Investigating non-attendance at colposcopy clinic. J Obstet Gynaecol 2002;22:79-80.
28. Katz SJ, Hofer TP. Socio-economic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA 1994;272:530-34.
29. Snider J, Beauvais J, Levy I, Villeneuve P, Pennock J. Trends in mammography and Pap smear utilization in Canada. Chron Dis Can 1996;17:108-17.
30. Snider JA, Beauvais JE. Pap smear utilization in Canada: Estimates after adjusting the eligible population for hysterectomy status. Chron Dis Can 1998;19:19-24.
31. Stuart GC, McGregor SE, Duggan MA, Nation JG. Review of the screening history of Alberta women with invasive cervical cancer. CMAJ 1997;157:513-19.
32. Parboosingh EJ, Anderson G, Clarke EA, Inhaber S, Kaegi E, Mills C, et al. Cervical cancer screening: Are the 1989 recommendations still valid? National Workshop on Screening for Cancer of the Cervix. CMAJ 1996;154:1847-53.
33. Grunfeld E. Cervical cancer: Screening hard-to-reach groups. CMAJ 1997;157:543-45.
34. Khanna N, Phillips MD. Adherence to care plan in women with abnormal Papanicolaou smears: A review of barriers and interventions. J Am Board Fam Practice 2001;14:123-30.
35. McKee MD, Lurio J, Marantz P, Burton W, Mulvihill M. Barriers to follow-up of abnormal Papanicolaou smears in an urban community health center. Arch Fam Medicine 1999;8:129-34.